tiprankstipranks
Advertisement
Advertisement

GLMD Stock Latest News

Morning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories!
Market NewsMorning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories!
5d ago
AMD
DIA
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
PremiumCompany Announcements
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
5d ago
6K
GLMD
Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?
PremiumMarket News
Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?
5d ago
GLMD
Galmed announces development of brain penetrating formulation of Aramchol
PremiumThe Fly
Galmed announces development of brain penetrating formulation of Aramchol
5d ago
GLMD
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting
PremiumCompany Announcements
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting
1M ago
6K
GLMD
Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum
PremiumCompany AnnouncementsGalmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum
1M ago
6K
GLMD
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency
Premium
Company Announcements
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency
2M ago
6K
GLMD
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice
Premium
Company Announcements
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice
2M ago
6K
GLMD
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
PremiumCompany Announcements
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
4M ago
GLMD
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
PremiumCompany Announcements
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
4M ago
6K
GLMD
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
PremiumCompany Announcements
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
4M ago
6K
GLMD
Galmed granted new Use Patent related to lead compound Aramchol
PremiumThe Fly
Galmed granted new Use Patent related to lead compound Aramchol
4M ago
GLMD
Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
PremiumCompany AnnouncementsGalmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
4M ago
6K
GLMD
Galmed issues CEO letter to shareholders
Premium
The Fly
Galmed issues CEO letter to shareholders
4M ago
GLMD
Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs
Premium
Company Announcements
Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs
5M ago
6K
GLMD
Galmed reports Q3 EPS (33c) vs. ($2.31) last year
PremiumThe Fly
Galmed reports Q3 EPS (33c) vs. ($2.31) last year
5M ago
GLMD
Galmed reports ‘meaningful’ results from AM-001 study of Aramchol meglumine
PremiumThe Fly
Galmed reports ‘meaningful’ results from AM-001 study of Aramchol meglumine
5M ago
GLMD
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
PremiumCompany Announcements
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
5M ago
6K
GLMD
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study
PremiumCompany Announcements
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study
5M ago
6K
GLMD
Galmed’s Aramchol and Bayer’s Stivarga show synergistic effect in GI cancers
PremiumThe FlyGalmed’s Aramchol and Bayer’s Stivarga show synergistic effect in GI cancers
5M ago
GLMD
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting
Premium
Company Announcements
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting
6M ago
6K
GLMD
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum
Premium
Company Announcements
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum
6M ago
6K
GLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >